Sam Eiber

Stock Analyst at BTIG

(n/a)

# 4,791

Out of 4,876 analysts

4

Total ratings

n/a

Success rate

-14.96%

Average return

Main Sectors:

Top Industries:

Medical Devices Drug Manufacturers - Specialty & Generic

Stocks Rated by Sam Eiber

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	INMD InMode	Downgrades: Neutral	n/a	$14.07	-	2	Apr 29, 2025
	EOLS Evolus	Initiates: Buy	$21	$9.31	+125.56%	1	Apr 17, 2025
	APYX Apyx Medical	Initiates: Neutral	n/a	$2.18	-	1	Oct 17, 2024

InMode

Apr 29, 2025

Downgrades: Neutral

Price Target: n/a

Current: $14.07

Upside: -

Evolus

Apr 17, 2025

Initiates: Buy

Price Target: $21

Current: $9.31

Upside: +125.56%

Apyx Medical

Oct 17, 2024

Initiates: Neutral

Price Target: n/a

Current: $2.18

Upside: -